Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ania Wysinski"'
Autor:
Dawn M Wong, Jianyong Li, Qiao-Hong Chen, Qian Han, James M Mutunga, Ania Wysinski, Troy D Anderson, Haizhen Ding, Tiffany L Carpenetti, Astha Verma, Rafique Islam, Sally L Paulson, Polo C-H Lam, Maxim Totrov, Jeffrey R Bloomquist, Paul R Carlier
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e46712 (2012)
Acetylcholinesterase (AChE) is a proven target for control of the malaria mosquito (Anopheles gambiae). Unfortunately, a single amino acid mutation (G119S) in An. gambiae AChE-1 (AgAChE) confers resistance to the AChE inhibitors currently approved by
Externí odkaz:
https://doaj.org/article/5787d6ace9ba45baa6e7309d3a591b29
Autor:
Polo C.-H. Lam, Jeffrey R. Bloomquist, Joshua A. Hartsel, Jianyong Li, Paul R. Carlier, Sally L. Paulson, Eric A. Wong, Rafique Islam, Ming Ma, Maxim Totrov, Dawn M. Wong, Troy D. Anderson, James M. Mutunga, Ania Wysinski
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:4593-4598
To identify potential human-safe insecticides against the malaria mosquito we undertook an investigation of the structure–activity relationship of aryl methylcarbamates inhibitors of acetylcholinesterase (AChE). Compounds bearing a β-branched 2-al
Autor:
Polo C.-H. Lam, Joshua A. Hartsel, Troy D. Anderson, Sally L. Paulson, James M. Mutunga, Jianyong Li, Eric A. Wong, Maxim Totrov, Dawn M. Wong, Rafique Islam, Ania Wysinski, Jeffrey R. Bloomquist, Ming Ma, Paul R. Carlier
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 23:5752
Autor:
James M. Mutunga, Jeffrey R. Bloomquist, Qian Han, Qiao-Hong Chen, Jianyong Li, Astha Verma, Ania Wysinski, Tiffany L. Carpenetti, Paul R. Carlier, Haizhen Ding, Troy D. Anderson, Sally L. Paulson, Maxim Totrov, Dawn M. Wong, Polo Chun Hung Lam, Rafique Islam
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e46712 (2012)
PLoS ONE
PLoS ONE
Acetylcholinesterase (AChE) is a proven target for control of the malaria mosquito (Anopheles gambiae). Unfortunately, a single amino acid mutation (G119S) in An. gambiae AChE-1 (AgAChE) confers resistance to the AChE inhibitors currently approved by